explore -WSS

explore

author：Wikipedia 2025-09-27 16:48:07 - browse：11954

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How CRISPR works, explained in two minutes

knowledge

WSS

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Many breast cancer patients receive more radiation than needed

SCOTUS questions limit to govt efforts to fight misinformation

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Stop the failed accountable care organization experiment

Failure, not just success, should guide future doctors

Wikipedia

explore

knowledge

Sports medicine is finally prioritizing gender equality

CVS Caremark has created a new ploy: the drug ‘rebate credit’

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

SCOTUS questions limit to govt efforts to fight misinformation

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Bluebird, CVS, Contineum

As demand for Covid shots wanes, Moderna seeks its next success

Baby aspirin cuts fat buildup in liver disease patients, in small study

Hepatitis C has a cure — but many Americans still lack access to it

Virtual Event: March of the Biosimilars

Wikipedia

Readout Newsletter: Bluebird, CVS, Contineum

Creating egg and sperm cells from stem cells raises ethical issues

Doctors are clamoring for more clarity on Paxlovid prescribing

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Nurses recount patients attacks

Neuroscience’s long legacy of racism

explore

focus

knowledge

leisure time